Company: HROW
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001641172-25-009263
Chunk: 45

Company: HARROW, INC.
Filing Date: 2025-05-08
Form: 10-Q
Item: Item 1
Chunk 45
---
 business or the risks associated with an investment
in our common stock. We urge you to carefully review and consider the various disclosures made by us in this Quarterly Report and in our
other reports filed with the U.S. Securities and Exchange Commission (the “SEC”), including our Annual Report on Form 10-K
for the fiscal year ended December 31, 2024 and subsequent reports, which discuss our business in greater detail. As used in this discussion
and analysis, unless the context indicates otherwise, the terms the “Company,” “Harrow,” “we,” “us”
and “our” refer to Harrow, Inc. and its consolidated subsidiaries, including ImprimisRx, LLC, ImprimisRx NJ, LLC dba ImprimisRx,
Imprimis NJOF, LLC, Harrow IP, LLC and Harrow Eye, LLC. In this discussion and analysis, we refer to our consolidated subsidiaries ImprimisRx,
LLC, ImprimisRx NJ, LLC and Imprimis NJOF, LLC collectively as “ImprimisRx.”

In
addition to historical information, the following discussion contains forward-looking statements regarding future events and our
future performance. In some cases, you can identify forward-looking statements by terminology such as “will,”
“may,” “should,” “expects,” “plans,” “anticipates,”
“believes,” “estimates,” “predicts,” “forecasts,” “potential” or
“continue” or the negative of these terms or other comparable terminology. All statements made in this Quarterly Report
other than statements of historical fact are forward-looking statements. These forward-looking statements involve risks and
uncertainties and reflect only our current views, expectations and assumptions with respect to future events and our future
performance. If risks or uncertainties materialize or assumptions prove incorrect, actual results or events could differ materially
from those expressed or implied by such forward-looking statements. Risks that could cause actual results to differ from those
expressed or implied by the forward-looking statements we make include, among others, risks related to: liquidity or results of
operations; our ability to successfully implement our business plan, develop and commercialize our products, product candidates and
proprietary formulations in a timely manner or at all, identify and acquire additional products, manage our pharmacy operations,
refinance and otherwise service our debt, obtain financing necessary to operate our business, recruit and retain qualified
personnel, manage any growth we may experience and successfully realize the benefits of